United States
Print page content Print
Increase text size Decrease text size
Text Size
SIMBADOL buprenorphine injection

ONCE-DAILY* 24‑HOUR CONTINUOUS SURGICAL PAIN CONTROL FOR CATS

The only FDA approved buprenorphine for cats ORDER SIMBADOL
Watch Simbadol’s Mechanism of Action.

See full Prescribing Information, including the complete Boxed Warning for human safety.

PROVEN EFFICACY
AND SAFETY

In two large clinical studies, SIMBADOL
(buprenorphine injection) was well
tolerated and demonstrated safety and
efficacy for postoperative pain control
in cats.2

SUBCUTANEOUS
INJECTION ONCE DAILY

SIMBADOL administered subcutaneously once daily on days one (60 minutes before surgery), two and three.1

SIGNIFICANTLY GREATER
TREATMENT SUCCESS FOR
SIMBADOL TREATED CATS

Successful treatment defined as a cat not requiring rescue analgesia during the 72-hour observation period.

MILD ADVERSE
EVENTS

In Soft Tissue Surgery and Orthopedic Surgery studies, the majority of adverse events were mild in severity and either typical opioid reactions or were similar to the placebo group in frequency.3,4

Learn more in research studies
LEARN MORE

STREAMLINE
POSTOPERATIVE
PAIN MANAGEMENT FOR CATS

With one dose, your feline patients get 24 hours of continuous postoperative pain control, while saving your staff the time and effort of multiple injections.

SIMBADOL 24-hour SIMBADOL 24-hour

24 HOURS OF CONTINUOUS
PAIN CONTROL FOR CATS

SIMBADOL lasts as long as three or four doses of other feline pain medications

ONE INJECTION

ADMINISTERED IN-CLINIC

100% COMPLIANCE

COST COMPETITIVE

Try SIMBADOL Today
ORDER SIMBADOL

INDICATION: SIMBADOL is indicated for the control of postoperative pain associated with surgical procedures in cats.

See References for detailed information about research studies referenced on this website.

IMPORTANT SAFETY INFORMATION: Due to serious human safety and abuse concerns, including physical or psychological dependence, life-threatening respiratory depression and additive CNS depressant effects, read the full prescribing information before using this drug, including the complete Boxed Warning. Not for use in humans. Hospital staff should be trained in the handling of potent opioids and should avoid accidental exposure. SIMBADOL has not been evaluated in breeding, pregnant, or lactating cats, in cats younger than 4 months of age or moribund cats. Do not use in cats with known hypersensitivity to buprenorphine hydrochloride or any of the components of SIMBADOL, or known intolerance to opioids. Use with caution in cats with impaired hepatic function. Adverse reactions may include hyperthermia, tachycardia, hypotension, hypertension, hypothermia, anorexia, and hyperactivity. For more safety information, refer to the full Prescribing Information.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
© 2016 Zoetis Services LLC. All rights reserved. SIM-00052